Semaglutide has emerged as a novel treatment for chronic diseases. This engineered glucagon-like peptide-1 (GLP-1) receptor agonist acts upon stimulating the pancreas to produce more insulin and suppressing glucagon https://matteoatkq599537.csublogs.com/42932763/understanding-semaglutide-a-comprehensive-guide